Arugula-derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04883-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Nosyba A Ibrahim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, College of Public Health and Health Informatics, University of Ha'il, Ha'il, Saudi Arabia. Hauptthemen laut MEDLINE: Isothiocyanates, Breast Neoplasms, Aldehyde Reductase, Brassicaceae. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Scientific Research Deanship at University of Ha'il-Saudi Arabia, Scientific Research Deanship at University of Ha’il-Saudi Arabia.
Abstract (Originalsprache)
Breast cancer (BC) is a leading cause of cancer-related mortality, with estrogen receptor (ER)-negative subtypes, especially triple-negative BC, comprising one-fifth of global cases. Natural inhibitors, particularly those from cruciferous vegetables like arugula (Eruca sativa), which are rich in bioactive isothiocyanates (ITCs), show potent anticancer effects and cytoprotection when combined with chemotherapy. Sulforaphane (SFN) and its analogue erucin modulate oxidative stress, detoxification, and epigenetic pathways. This study computationally assessed their anti-cancer potential in ER-negative BC using transcriptomic analysis, molecular docking, and ADMET profiling. Microarray data (GSE28813) from SFN-treated ER-negative MCF10A cells were analyzed via GEO2R and GEOExplorer to identify highly upregulated differentially expressed genes (DEGs). Key DEGs included AKR1B10 (logFC = 7.26), AKR1C1 (logFC = 5.10), AKR1C3 (logFC = 4.42), NMRAL1P1 (logFC = 6.42), and HKDC1 (logFC = 6.13). Elevated AKR1B10 is strongly linked to early BC malignancies, positioning it as a diagnostic and therapeutic target. Molecular docking showed SFN's superior binding affinity to AKR1B10 compared to erucin, with strong interactions at catalytic site residues via hydrogen and hydrophobic bonds. ADMET profiling confirmed SFN's high intestinal absorption and blood-brain barrier non-permeability. Thus, integrating SFN as a natural AKR1B10 inhibitor into ER-negative BC treatment regimens may enhance early malignancy management and support its development as a nutraceutical adjunct.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, College of Public Health and Health Informatics, University of Ha'il, Ha'il, Saudi Arabia.
- Medical and Diagnostic Research Center, University of Ha'il, Ha'il, 55473, Saudi Arabia.
- Department of Clinical Nutrition, College of Applied Medical Sciences, University of Ha'il, P.O. Box 2440, Ha'il, Saudi Arabia.
- Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, 51452, Buraydah, Saudi Arabia.
- Center for Virology, School of Interdisciplinary Science and Technology (SIST), Jamia Hamdard, New Delhi-110062, India. mirzasbaig@jamiahamdard.ac.in.
- Medical and Diagnostic Research Center, University of Ha'il, Ha'il, 55473, Saudi Arabia. amirashrafy2007@gmail.com.
Förderung
- Scientific Research Deanship at University of Ha'il-Saudi Arabia
- Scientific Research Deanship at University of Ha’il-Saudi Arabia
Zitieren
APA
Ibrahim, N. A., Sherfi, H. A., Azam, F., Al Shammari, E., Baig, M. S., & Ashraf, S. A. (2025). Arugula-derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04883-5
Vancouver
Ibrahim NA, Sherfi HA, Azam F, Al Shammari E, Baig MS, Ashraf SA. Arugula-derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04883-5
BibTeX
@article{Ibrahim2025,
author = {Ibrahim, Nosyba A and Sherfi, Huda A and Azam, Faizul and Al Shammari, Eyad and Baig, Mirza Sarwar and Ashraf, Syed Amir},
title = {Arugula-derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04883-5}
}
EUVIMED